Cargando…
Music medicine to improve the tolerability of onabotulinumtoxinA injections for chronic migraine: an open-label prospective cohort study
INTRODUCTION: OnabotulinumtoxinA for migraine involves 31 injected repeated every 12 weeks. Tolerability is a significant factor impacting discontinuation. Music medicine has not been studied previously as an intervention to improve the tolerability of injections. METHODOLOGY: A single-centre prospe...
Autores principales: | Ray, Jason, Raviskanthan, Subahari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533660/ https://www.ncbi.nlm.nih.gov/pubmed/37780681 http://dx.doi.org/10.1136/bmjno-2023-000492 |
Ejemplares similares
-
Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
por: Hermanowicz, Neal
Publicado: (2021) -
OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients
por: García-Sáez, Rafael, et al.
Publicado: (2018) -
An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
por: Ahmed, Fayyaz, et al.
Publicado: (2019) -
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
por: Diener, H-C, et al.
Publicado: (2014) -
OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy
por: Ray, Jason C., et al.
Publicado: (2021)